| Literature DB >> 25001280 |
Shu-Ichi Okamoto1, Tomohiro Nakamura2, Piotr Cieplak3, Shing Fai Chan2, Evgenia Kalashnikova2, Lujian Liao4, Sofiyan Saleem2, Xuemei Han4, Arjay Clemente2, Anthony Nutter2, Sam Sances2, Christopher Brechtel2, Daniel Haus2, Florian Haun2, Sara Sanz-Blasco2, Xiayu Huang3, Hao Li2, Jeffrey D Zaremba2, Jiankun Cui2, Zezong Gu2, Rana Nikzad2, Anne Harrop2, Scott R McKercher2, Adam Godzik3, John R Yates4, Stuart A Lipton5.
Abstract
Redox-mediated posttranslational modifications represent a molecular switch that controls major mechanisms of cell function. Nitric oxide (NO) can mediate redox reactions via S-nitrosylation, representing transfer of an NO group to a critical protein thiol. NO is known to modulate neurogenesis and neuronal survival in various brain regions in disparate neurodegenerative conditions. However, a unifying molecular mechanism linking these phenomena remains unknown. Here, we report that S-nitrosylation of myocyte enhancer factor 2 (MEF2) transcription factors acts as a redox switch to inhibit both neurogenesis and neuronal survival. Structure-based analysis reveals that MEF2 dimerization creates a pocket, facilitating S-nitrosylation at an evolutionally conserved cysteine residue in the DNA binding domain. S-Nitrosylation disrupts MEF2-DNA binding and transcriptional activity, leading to impaired neurogenesis and survival in vitro and in vivo. Our data define a molecular switch whereby redox-mediated posttranslational modification controls both neurogenesis and neurodegeneration via a single transcriptional signaling cascade.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25001280 PMCID: PMC4114155 DOI: 10.1016/j.celrep.2014.06.005
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423